Terpyridines as promising antitumor agents: an overview of their discovery and development

References

• Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019 Jul;88:102925.
   PubMed Web of Science ®Google Scholar
• Allardyce CS, Dyson PJ. Metal-based drugs that break the rules. Dalton Trans. 2016 Feb 28; 45(8):3201–3209.
   PubMed Web of Science ®Google Scholar
• Ndagi U, Mhlongo N, Soliman ME. Metal complexes in cancer therapy - an update from drug design perspective. Drug Des Devel Ther. 2017;11:599–616.
   PubMed Web of Science ®Google Scholar
• Monro S, Colon KL, Yin H, et al. Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433. Chem Rev. 2019 Jan 23 119(2):797–828.
   PubMed Web of Science ®Google Scholar
• Reedijk J. New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. Proc Natl Acad Sci U S A. 2003 Apr 1; 100(7):3611–3616.
   PubMed Web of Science ®Google Scholar
• Boros E, Dyson PJ, Gasser G. Classification of metal-based drugs according to their mechanisms of action. Chem. 2020 Jan 9; 6(1):41–60.
   PubMed Web of Science ®Google Scholar
• Queyriaux N, Abel K, Fize J, et al. From non-innocent to guilty: on the role of redox-active ligands in the electro-assisted reduction of CO2 mediated by a cobalt(ii)-polypyridyl complex. Sustainable Energy Fuels. 2020;4(7):3668–3676.
   Web of Science ®Google Scholar
• Wei C, He Y, Shi X, et al. Terpyridine-metal complexes: applications in catalysis and supramolecular chemistry. Coord Chem Rev. 2019 Apr 15;385:1–19.
   PubMed Web of Science ®Google Scholar
• Schwarz G, Hasslauer I, Kurth DG. From terpyridine-based assemblies to metallo-supramolecular polyelectrolytes (MEPEs). Adv Colloid Interface Sci. 2014 May;207:107–120.
   PubMed Web of Science ®Google Scholar
• Xie TZ, Yao Y, Sun X, et al. Supramolecular arrays by the self-assembly of terpyridine-based monomers with transition metal ions. Dalton Trans. 2018 Jun 5 47(22):7528–7533.
   PubMed Web of Science ®Google Scholar
• Saccone D, Magistris C, Barbero N, et al. Terpyridine and quaterpyridine complexes as sensitizers for photovoltaic applications. Materials (Basel). 2016 Feb 27 9(3):137.
   Web of Science ®Google Scholar
• Ye YX, Wen C, Wang JW, et al. Valence-dependent catalytic activities of iron terpyridine complexes for pollutant degradation. Chem Commun (Camb). 2020 May 21 56(41):5476–5479.
   PubMed Web of Science ®Google Scholar
• Juneja A, Macedo TS, Magalhaes Moreira DR, et al. Synthesis of 4′-(2-ferrocenyl)-2,2′:6′2′′-terpyridine: characterization and antiprotozoal activity of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) complexes. Eur J Med Chem. 2014 Mar 21;75:203–210.
   PubMed Web of Science ®Google Scholar
• Hadda TB, Akkurt M, Baba MF, et al. Anti-tubercular activity of ruthenium (II) complexes with polypyridines. J Enzyme Inhib Med Chem. 2009 Apr;24(2):457–463.
   PubMed Web of Science ®Google Scholar
• Anthonysamy A, Balasubramanian S, Shanmugaiah V, et al. Synthesis, characterization and electrochemistry of 4ʹ-functionalized 2,2ʹ:6ʹ,2”-terpyridine ruthenium(II) complexes and their biological activity. Dalton Trans. 2008 Apr;28(16):2136–2143.
   Google Scholar
• Qiao J, Purro M, Liu Z, et al. Terpyridine-micelles for inhibiting bacterial biofilm development. ACS Infect Dis. 2018 Sep 14 4(9):1346–1354.
   PubMed Web of Science ®Google Scholar
• Hunter RC, Asfour F, Dingemans J, et al. Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. mBio. 2013 Aug 20;4(4). https://doi.org/10.1128/mBio.00557-13.
   Google Scholar
• Crans DC, Kostenkova K. Open questions on the biological roles of first-row transition metals. Communications Chemistry. 2020;3(1). https://doi.org/10.1038/s42004-020-00341-w
   Google Scholar
• Winter A, Gottschaldt M, Newkome GR, et al., Terpyridines and their complexes with first row transition metal ions: cytotoxicity, nuclease activity and self-assembly of biomacromolecules. Curr Top Med Chem. 2012;12(3): 158–175.
   PubMed Web of Science ®Google Scholar
• Sanchez Delgado GY, Paschoal D, de Oliveira MAL, et al. Structure and redox stability of [Au(III)(X^N^X)PR3] complexes (X=C or N) in aqueous solution: the role of phosphine auxiliary ligand. J Inorg Biochem. 2019 Nov;200:110804.
   PubMed Web of Science ®Google Scholar
• Holyer RH, Hubbard CD, Kettle SFA, et al. The kinetics of replacement reactions of complexes of the transition metals with 2,2ʹ,2”-Terpyridine. Inorg Chem. 2002;5(4):622–625.
   Google Scholar
• Schubert US, Winter A, Newkome GR. Terpyridine-based materials: for catalytic, optoelectronic and life science applications. Weinheim: Wiley-VCH; 2011.
   Google Scholar
• Chen YWD, Santhanam KSV, Bard AJ. Solution redox couples for electrochemical energy storage: i. Iron (III)‐Iron (II) Complexes with O‐Phenanthroline and related ligands. J Electrochem Soc. 2019;128(7):1460–1467.
   Google Scholar
• Fenton HJH. LXXIII.—Oxidation of tartaric acid in presence of iron. J Chem Soc, Trans. 1894;65:899–910.
   Google Scholar
• Verbon EH, Post JA, Boonstra J. The influence of reactive oxygen species on cell cycle progression in mammalian cells. Gene. 2012 Dec 10; 511(1):1–6.
   PubMed Web of Science ®Google Scholar
• Hage JP, Llobet A, Sawyer DT. Aromatic hydroxylation by fenton reagents {Reactive intermediate[Lx+FeIIIOOH(BH+)], not free hydroxyl radical (HO·)}. Bioorg Med Chem. 1995;3(10):1383–1388.
   PubMed Web of Science ®Google Scholar
• Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett. 1995;82-83:969–974.
   PubMed Web of Science ®Google Scholar
• Miller CJ, Rose AL, Waite TD. Importance of iron complexation for fenton-mediated hydroxyl radical production at circumneutral pH. Frontiers in Marine Sci. 2016;3. https://doi.org/10.3389/fmars.2016.00134.
   Google Scholar
• Beller G, Lente G, Fabian I. Kinetics and mechanism of the autocatalytic oxidation of Bis(terpyridine)iron(II) by Peroxomonosulfate Ion (Oxone) in acidic medium. Inorg Chem. 2017 Jul 17; 56(14):8270–8277.
   PubMed Web of Science ®Google Scholar
• Dickenson JC, Haley ME, Hyde JT, et al. Fine-Tuning metal and ligand-centered redox potentials of homoleptic bis-terpyridine complexes with 4ʹ-Aryl Substituents. Inorg Chem. 2021 Jul 5 60(13):9956–9969.
   PubMed Web of Science ®Google Scholar
• Grau J, Caubet A, Roubeau O, et al. Time-dependent cytotoxic properties of terpyridine-based copper complexes. Chembiochem. 2020 Aug 17 21(16):2348–2355.
   PubMed Web of Science ®Google Scholar
• Manikandamathavan VM, Weyhermuller T, Parameswari RP, et al. DNA/protein interaction and cytotoxic activity of imidazole terpyridine derived Cu(II)/Zn(II) metal complexes. Dalton Trans. 2014 Sep 14 43(34):13018–13031.
   PubMed Web of Science ®Google Scholar
• Liang X, Jiang J, Xue X, et al. Synthesis, characterization, photoluminescence, anti-tumor activity, DFT calculations and molecular docking with proteins of zinc(ii) halogen substituted terpyridine compounds. Dalton Trans. 2019;48(28):10488–10504.
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Zucman-Rossi J, Moreau R, et al. Note of caution: contaminations of hepatocellular cell lines. J Hepatol. 2017 Nov;67(5):896–897.
   PubMed Web of Science ®Google Scholar
• Liang JW, Wang Y, Du KJ, et al. Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4ʹ-phenyl-2,2ʹ:6ʹ,2”-terpyridine derivatives. J Inorg Biochem. 2014 Dec;141:17–27.
   PubMed Web of Science ®Google Scholar
• Wu S, Wang X, He Y, et al. A monofunctional trinuclear platinum complex with steric hindrance demonstrates strong cytotoxicity against tumor cells. J Inorg Biochem. 2014 Oct;139:77–84.
   PubMed Web of Science ®Google Scholar
• Morel E, Beauvineau C, Naud-Martin D, et al. Selectivity of terpyridine platinum anticancer drugs for G-quadruplex DNA. Molecules. 2019 Jan 23 24(3):404.
   Web of Science ®Google Scholar
• Kumar A, Chinta JP, Ajay AK, et al. Synthesis, characterization, plasmid cleavage and cytotoxicity of cancer cells by a copper(II) complex of anthracenyl-terpyridine [https://doi.org/10.1039/C1DT10201J]. Dalton Trans. 2011 Nov 7;40(41):10865–10872.
   PubMed Web of Science ®Google Scholar
• Maity B, Gadadhar S, Goswami TK, et al. Impact of metal on the DNA photocleavage activity and cytotoxicity of ferrocenyl terpyridine 3d metal complexes [https://doi.org/10.1039/C1DT11102G]. Dalton Trans. 2011 Nov 28;40(44):11904–11913.
   PubMed Web of Science ®Google Scholar
• Heaney EK, Logan SR. Photo-oxidation of ferrocenyl-substituted carboxylic acids [https://doi.org/10.1039/P29780000590]. J Chem Soc Perkin Trans. 1978 6;2:590–594.
   Google Scholar
• Basu U, Khan I, Koley D, et al. Nuclear targeting terpyridine iron(II) complexes for cellular imaging and remarkable photocytotoxicity. J Inorg Biochem. 2012 Nov;116:77–87.
   PubMed Web of Science ®Google Scholar
• Jain S, Bhar K, Kumar S, et al. Homo- and heteroleptic trimethoxy terpyridine-Cu(ii) complexes: synthesis, characterization, DNA/BSA binding, DNA cleavage and cytotoxicity studies. Dalton Trans. 2020 Apr 1 49(13):4100–4113.
   PubMed Web of Science ®Google Scholar
• Deka B, Sarkar T, Banerjee S, et al. Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity. Dalton Trans. 2017 Jan 3 46(2):396–409.
   PubMed Web of Science ®Google Scholar
• Czaplinska B, Spaczynska E, Musiol R. Quinoline fluorescent probes for Zinc - from diagnostic to therapeutic molecules in treating neurodegenerative diseases. Med Chem. 2018;14(1):19–33.
   PubMed Web of Science ®Google Scholar
• Czaplinska B, Malarz K, Mrozek-Wilczkiewicz A, et al. Theoretical and experimental investigations of large stokes shift fluorophores based on a Quinoline Scaffold. Molecules. 2020 May 27 25(11):2488.
   Web of Science ®Google Scholar
• Czaplinska B, Malarz K, Mrozek-Wilczkiewicz A, et al. Acid selective pro-dye for cellular compartments. Sci Rep. 2019 Oct 25 9(1):15304.
   PubMedGoogle Scholar
• Choroba K, Machura B, Szlapa-Kula A, et al. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2ʹ:6ʹ,2”-terpyridine ligands: from in vitro to in vivo biological properties. Eur J Med Chem. 2021 Jun 5;218:113404.
   PubMed Web of Science ®Google Scholar
• Mishra S, Tamta AK, Sarikhani M, et al. Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy. Sci Rep. 2018 Apr 4 8(1):5599.
   PubMedGoogle Scholar
• Ehrlich P, Apolant H. Beobachtungen Über Maligne Mausentumoren. Vol. 28. Berlin Klin Wschr. 1905, 871–874
   Google Scholar
• Mahendiran D, Kumar RS, Viswanathan V, et al. In vitro and in vivo anti-proliferative evaluation of bis(4ʹ-(4-tolyl)-2,2ʹ:6ʹ,2”-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors. J Biol Inorg Chem. 2017 Oct;22(7):1109–1122.
   PubMed Web of Science ®Google Scholar
• Guney E, Yilmaz VT, Sengul A, et al. Platinum(II) and palladium(II) saccharinato complexes with 2,2′:6′,2″-terpyridine: synthesis, characterization, crystal structures, photoluminescence and thermal studies. Inorganica Chim Acta. 2010;363(2):438–448.
   Web of Science ®Google Scholar
• Ari F, Aztopal N, Icsel C, et al. Synthesis, structural characterization and cell death-inducing effect of novel palladium(II) and platinum(II) saccharinate complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine on cancer cells in vitro. Bioorg Med Chem. 2013 Nov 1 21(21):6427–6434.
   PubMed Web of Science ®Google Scholar
• Ulukaya E, Ari F, Dimas K, et al. Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro. J Cancer Res Clin Oncol. 2011 Oct;137(10):1425–1434.
   PubMed Web of Science ®Google Scholar
• Ulukaya E, Ari F, Dimas K, et al. Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo. Eur J Med Chem. 2011 Oct;46(10):4957–4963.
   PubMed Web of Science ®Google Scholar
• Ikitimur-Armutak EI, Sonmez K, Akgun-Dar K, et al. Anticancer effect of a novel palladium-saccharinate complex of terpyridine by inducing apoptosis on Ehrlich ascites carcinoma (EAC) in Balb-C mice. Anticancer Res. 2015 Mar;35(3):1491–1497.
   PubMed Web of Science ®Google Scholar
• Ikitimur-Armutak EI, Ulukaya E, Gurel-Gurevin E, et al. Apoptosis-inducing effect of a Palladium(II) Complex-[PdCl(terpy)](sac).2H2O] on Ehrlich Ascites Carcinoma (EAC) in Mice. Vivo. 2016 Jul-Aug;30(4):457–464.
   PubMed Web of Science ®Google Scholar
• McFadyen WD, Wakelin LP, Roos IA, et al. Activity of platinum(II) intercalating agents against murine leukemia L1210. J Med Chem. 1985 Aug;28(8):1113–1116.
   PubMed Web of Science ®Google Scholar
• Messori L, Abbate F, Marcon G, et al. Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. J Med Chem. [2000 Sep 21];43(19):3541–3548.
   PubMed Web of Science ®Google Scholar
• Shi P, Jiang Q, Zhao Y, et al. DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects. J Biol Inorg Chem. 2006 Sep;11(6):745–752.
   PubMed Web of Science ®Google Scholar
• Zhao LX, Sherchan J, Park JK, et al. Synthesis, cytotoxicity and structure-activity relationship study of terpyridines. Arch Pharm Res. 2006 Dec;29(12):1091–1095.
   PubMed Web of Science ®Google Scholar
• Zhao L-X, Kim TS, Ahn S-H, et al. Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-Terpyridine derivatives. Bioorg Med Chem Lett. 2001;11(19):2659–2662.
   PubMed Web of Science ®Google Scholar
• Kwon HB, Park C, Jeon KH, et al. A series of novel terpyridine-skeleton molecule derivants inhibit tumor growth and metastasis by targeting topoisomerases. J Med Chem. 2015 Feb 12 58(3):1100–1122.
   PubMed Web of Science ®Google Scholar
• Jeong B-S, Choi H-Y, Kwak Y-S, et al. Synthesis of 2,4,6-Tripyridyl pyridines, and evaluation of their antitumor cytotoxicity, topoisomerase i and ii inhibitory activity, and structure-activity relationship. Bull Korean Chem Soc. 2011;32(10):3566–3570.
   Web of Science ®Google Scholar
• Son J-K, Zhao L-X, Basnet A, et al. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities. Eur J Med Chem. 2008;43(4):675–682.
   PubMed Web of Science ®Google Scholar
• Karki R, Thapa P, Kwon Y-J, et al. Synthesis, topoisomerase I and II inhibitory activities, and cytotoxicity of 4,6-Diaryl-2,4ʹ-bipyridine Derivatives. Bull Korean Chem Soc. 2010;31(6):1747–1750.
   Web of Science ®Google Scholar
• Thapa P, Lee E-S. 2,4-Diaryl-5,6-dihydro-1,10-phenanthrolines with Furyl or Thienyl Moiety at 4-position: synthesis, topoisomerase I and II inhibitory activity, and cytotoxicity. Bull Korean Chem Soc. 2012;33(5):1769–1772.
   Web of Science ®Google Scholar
• Lo YC, Ko TP, Su WC, et al. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1. J Inorg Biochem. 2009 Jul;103(7):1082–1092.
   PubMed Web of Science ®Google Scholar
• Vrábel M, Hocek M, Havran L, et al. Purines bearing phenanthroline or bipyridine ligands and their ruii complexes in position 8 as model compounds for electrochemical DNA labeling – synthesis, crystal structure, electrochemistry, quantum chemical calculations, cytostatic and antiviral activity. Eur J Inorg Chem. 2007;2007(12):1752–1769.
   Google Scholar
• Jiang Q, Zhu J, Zhang Y, et al. DNA binding property, nuclease activity and cytotoxicity of Zn(II) complexes of terpyridine derivatives. Biometals. 2009 Apr;22(2):297–305.
   PubMed Web of Science ®Google Scholar
• Darabi F, Hadadzadeh H, Simpson J, et al., A water-soluble Pd(ii) complex with a terpyridine ligand: experimental and molecular modeling studies of the interaction with DNA and BSA; and in vitro cytotoxicity investigations against five human cancer cell lines. New J Chem. 2016;40(11): 9081–9097.
   Web of Science ®Google Scholar
• Maron A, Czerwinska K, Machura B, et al. Spectroscopy, electrochemistry and antiproliferative properties of Au(iii), Pt(ii) and Cu(ii) complexes bearing modified 2,2ʹ:6ʹ,2”-terpyridine ligands. Dalton Trans. 2018 May 8 47(18):6444–6463.
   PubMed Web of Science ®Google Scholar
• Qin QP, Meng T, Tan MX, et al. Synthesis, characterization and biological evaluation of six highly cytotoxic ruthenium(ii) complexes with 4ʹ-substituted-2,2ʹ:6ʹ,2”-terpyridine. Medchemcomm. 2018 Mar 1 9(3):525–533.
   PubMed Web of Science ®Google Scholar
• Zych D, Slodek A, Krompiec S, et al. 4′-Phenyl-2,2′:6′,2′′-terpyridine derivatives containing 1-Substituted-2,3-Triazole ring: synthesis, characterization and anticancer activity. ChemistrySelect. 2018;3(24):7009–7017.
   Web of Science ®Google Scholar
• Malarz K, Zych D, Kuczak M, et al. Anticancer activity of 4ʹ-phenyl-2,2ʹ:6ʹ,2”-terpyridines - behind the metal complexation. Eur J Med Chem. 2020 Mar 1;189:112039.
   PubMed Web of Science ®Google Scholar
• Pugazhendhi A, Edison T, Velmurugan BK, et al. Toxicity of Doxorubicin (Dox) to different experimental organ systems. Life Sci. 2018 May 1;200:26–30.
   PubMed Web of Science ®Google Scholar
• Malarz K, Mrozek-Wilczkiewicz A, Serda M, et al. The role of oxidative stress in activity of anticancer thiosemicarbazones. Oncotarget. 2018 Apr 3 9(25):17689–17710.
   PubMedGoogle Scholar
• Malarz K, Zych D, Gawecki R, et al. New derivatives of 4ʹ-phenyl-2,2ʹ:6ʹ,2”-terpyridine as promising anticancer agents. Eur J Med Chem. 2021 Feb 15;212:113032.
   PubMed Web of Science ®Google Scholar
• Durand N, Storz P. Targeting reactive oxygen species in development and progression of pancreatic cancer. Expert Rev Anticancer Ther. 2017 Jan;17(1):19–31.
   PubMed Web of Science ®Google Scholar
• Peric T, Jakovljevic V, Zivkovic V, et al. Toxic effects of palladium compounds on the isolated rat heart. Med Chem. 2012 Jan;8(1):9–13.
   PubMed Web of Science ®Google Scholar
• Christensen GM. Effects of metal cations and other chemicals upon the in vitro activity of two enzymes in the blood plasma of the white sucker, catostomus commersoni (lacépède). Chem Biol Interact. 1972;4(5):351–361.
   PubMed Web of Science ®Google Scholar
• Bunger J, Stork J, Stalder K. Cyto- and genotoxic effects of coordination complexes of platinum, palladium and rhodium in vitro. Int Arch Occup Environ Health. 1996;69(1):33–38.
   PubMed Web of Science ®Google Scholar
• Dragutan I, Dragutan V, Demonceau A. Editorial of special issue ruthenium complex: the expanding chemistry of the ruthenium complexes. Molecules. 2015 Sep 18; 20(9):17244–17274.
   PubMed Web of Science ®Google Scholar
• Bochevarov AD, Harder E, Hughes TF, et al. Jaguar: a high‐performance quantum chemistry software program with strengths in life and materials sciences. Int J Quantum Chem. 2013;113(18):2110–2142.
   Web of Science ®Google Scholar
• Icard P, Fournel L, Wu Z, et al. Interconnection between metabolism and cell cycle in cancer. Trends Biochem Sci. 2019 Jun;44(6):490–501.
   PubMed Web of Science ®Google Scholar
• Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004 Apr 19; 23(18):3151–3171.
   PubMed Web of Science ®Google Scholar
• Chiu J, Dawes IW. Redox control of cell proliferation. Trends Cell Biol. 2012 Nov;22(11):592–601.
   PubMed Web of Science ®Google Scholar
• Patterson JC, Joughin BA, van de Kooij B, et al. ROS and oxidative stress are elevated in mitosis during asynchronous cell cycle progression and are exacerbated by mitotic arrest. Cell Syst. 2019 Feb 27 8(2):163–167 e2.
   PubMed Web of Science ®Google Scholar
• Chen Z, Odstrcil EA, Tu BP, et al. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science. 2007 Jun 29 316(5833):1916–1919.
   PubMed Web of Science ®Google Scholar
• Rajalakshmi S, Weyhermuller T, Dinesh M, et al. Copper(II) complexes of terpyridine derivatives: a footstep towards development of antiproliferative agent for breast cancer. J Inorg Biochem. 2012 Dec;117:48–59.
   PubMed Web of Science ®Google Scholar
• Savic M, Arsenijevic A, Milovanovic J, et al. Antitumor activity of Ruthenium(II) terpyridine complexes towards colon cancer cells in vitro and in vivo. Molecules. 2020 Oct 14 25(20):4699.
   Web of Science ®Google Scholar
• Mitra K, Basu U, Khan I, et al. Remarkable anticancer activity of ferrocenyl-terpyridine platinum(ii) complexes in visible light with low dark toxicity. Dalton Trans. 2014 Jan 14 43(2):751–763.
   PubMed Web of Science ®Google Scholar
• Kacar O, Cevatemre B, Hatipoglu I, et al. The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridine. Bioorg Med Chem. 2017 Mar 15;25(6):1770–1777.
   PubMed Web of Science ®Google Scholar
• Bormio Nunes JH, Hager S, Mathuber M, et al. Cancer cell resistance against the clinically investigated thiosemicarbazone COTI-2 Is based on formation of intracellular copper complex glutathione adducts and ABCC1-mediated efflux. J Med Chem. 2020 Nov 25 63(22):13719–13732.
   PubMed Web of Science ®Google Scholar
• Serda M, Kalinowski DS, Rasko N, et al. Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships. PLoS One. 2014;9(10):e110291.
   PubMed Web of Science ®Google Scholar